C12N 1/00
|
Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor |
C12N 1/02
|
Separating microorganisms from their culture media |
C12N 1/04
|
Preserving or maintaining viable microorganisms |
C12N 1/06
|
Lysis of microorganisms |
C12N 1/08
|
Reducing the nucleic acid content |
C12N 1/10
|
ProtozoaCulture media therefor |
C12N 1/11
|
ProtozoaCulture media therefor modified by introduction of foreign genetic material |
C12N 1/12
|
Unicellular algaeCulture media therefor |
C12N 1/13
|
Unicellular algaeCulture media therefor modified by introduction of foreign genetic material |
C12N 1/14
|
Fungi Culture media therefor |
C12N 1/15
|
Fungi Culture media therefor modified by introduction of foreign genetic material |
C12N 1/16
|
YeastsCulture media therefor |
C12N 1/18
|
Baker's yeastBrewer's yeast |
C12N 1/19
|
YeastsCulture media therefor modified by introduction of foreign genetic material |
C12N 1/20
|
BacteriaCulture media therefor |
C12N 1/21
|
BacteriaCulture media therefor modified by introduction of foreign genetic material |
C12N 1/22
|
Processes using, or culture media containing, cellulose or hydrolysates thereof |
C12N 1/24
|
Processes using, or culture media containing, waste sulfite liquor |
C12N 1/26
|
Processes using, or culture media containing, hydrocarbons |
C12N 1/28
|
Processes using, or culture media containing, hydrocarbons aliphatic |
C12N 1/30
|
Processes using, or culture media containing, hydrocarbons aliphatic having five or less carbon atoms |
C12N 1/32
|
Processes using, or culture media containing, lower alkanols, i.e. C1 to C6 |
C12N 1/34
|
Processes using foam culture |
C12N 1/36
|
Adaptation or attenuation of cells |
C12N 1/38
|
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factorsStimulation of growth by removal of a chemical compound |
C12N 3/00
|
Spore-forming or isolating processes |
C12N 5/00
|
Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor |
C12N 5/02
|
Propagation of single cells or cells in suspensionMaintenance thereofCulture media therefor |
C12N 5/04
|
Plant cells or tissues |
C12N 5/07
|
Animal cells or tissues |
C12N 5/09
|
Tumour cells |
C12N 5/10
|
Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells |
C12N 5/12
|
Fused cells, e.g. hybridomas |
C12N 5/14
|
Plant cells |
C12N 5/16
|
Animal cells |
C12N 5/18
|
Murine cells, e.g. mouse cells |
C12N 5/20
|
Murine cells, e.g. mouse cells one of the fusion partners being a B lymphocyte |
C12N 5/22
|
Human cells |
C12N 5/24
|
Human cells one of the fusion partners being a B lymphocyte |
C12N 5/26
|
Cells resulting from interspecies fusion |
C12N 5/28
|
Cells resulting from interspecies fusion one of the fusion partners being a human cell |
C12N 5/071
|
Vertebrate cells or tissues, e.g. human cells or tissues |
C12N 5/073
|
Embryonic cells or tissuesFoetal cells or tissues |
C12N 5/074
|
Adult stem cells |
C12N 5/075
|
OocytesOogonia |
C12N 5/076
|
Sperm cellsSpermatogonia |
C12N 5/077
|
Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells |
C12N 5/078
|
Cells from blood or from the immune system |
C12N 5/079
|
Neural cells |
C12N 5/095
|
Stem cellsProgenitor cells |
C12N 5/0735
|
Embryonic stem cellsEmbryonic germ cells |
C12N 5/0775
|
Mesenchymal stem cellsAdipose-tissue derived stem cells |
C12N 5/0781
|
B cellsProgenitors thereof |
C12N 5/0783
|
T cellsNK cellsProgenitors of T or NK cells |
C12N 5/0784
|
Dendritic cellsProgenitors thereof |
C12N 5/0786
|
MonocytesMacrophages |
C12N 5/0787
|
Granulocytes, e.g. basophils, eosinophils, neutrophils or mast cells |
C12N 5/0789
|
Stem cellsMultipotent progenitor cells |
C12N 5/0793
|
Neurons |
C12N 5/0797
|
Stem cellsProgenitor cells |
C12N 7/00
|
Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof |
C12N 7/01
|
Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material |
C12N 7/02
|
Recovery or purification |
C12N 7/04
|
Inactivation or attenuationProducing viral sub-units |
C12N 7/06
|
Inactivation or attenuationProducing viral sub-units by chemical treatment |
C12N 7/08
|
Inactivation or attenuationProducing viral sub-units by serial passage of virus |
C12N 9/00
|
Enzymes, e.g. ligases (6.)ProenzymesCompositions thereofProcesses for preparing, activating, inhibiting, separating, or purifying enzymes |
C12N 9/02
|
Oxidoreductases (1.), e.g. luciferase |
C12N 9/04
|
Oxidoreductases (1.), e.g. luciferase acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) |
C12N 9/06
|
Oxidoreductases (1.), e.g. luciferase acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) |
C12N 9/08
|
Oxidoreductases (1.), e.g. luciferase acting on hydrogen peroxide as acceptor (1.11) |
C12N 9/10
|
Transferases (2.) |
C12N 9/12
|
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7) |
C12N 9/14
|
Hydrolases (3.) |
C12N 9/16
|
Hydrolases (3.) acting on ester bonds (3.1) |
C12N 9/18
|
Carboxylic ester hydrolases |
C12N 9/20
|
Triglyceride splitting, e.g. by means of lipase |
C12N 9/22
|
Ribonucleases |
C12N 9/24
|
Hydrolases (3.) acting on glycosyl compounds (3.2) |
C12N 9/26
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase |
C12N 9/28
|
Alpha-amylase from microbial source, e.g. bacterial amylase |
C12N 9/30
|
Fungal source |
C12N 9/32
|
Alpha-amylase from plant source |
C12N 9/34
|
Glucoamylase |
C12N 9/36
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme |
C12N 9/38
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase |
C12N 9/40
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase |
C12N 9/42
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4-glucosidic bonds, e.g. cellulase |
C12N 9/44
|
Hydrolases (3.) acting on glycosyl compounds (3.2) acting on alpha-1, 6-glucosidic bonds, e.g. isoamylase, pullulanase |
C12N 9/46
|
Dextranase |
C12N 9/48
|
Hydrolases (3.) acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4) |
C12N 9/50
|
Proteinases |
C12N 9/52
|
Proteinases derived from bacteria |
C12N 9/54
|
Proteinases derived from bacteria bacteria being Bacillus |
C12N 9/56
|
Bacillus subtilis or Bacillus licheniformis |
C12N 9/58
|
Proteinases derived from fungi |
C12N 9/60
|
Proteinases derived from fungi from yeast |
C12N 9/62
|
Proteinases derived from fungi from Aspergillus |
C12N 9/64
|
Proteinases derived from animal tissue, e.g. rennin |
C12N 9/66
|
Elastase |
C12N 9/68
|
Plasmin, i.e. fibrinolysin |
C12N 9/70
|
Streptokinase |
C12N 9/72
|
Urokinase |
C12N 9/74
|
Thrombin |
C12N 9/76
|
TrypsinChymotrypsin |
C12N 9/78
|
Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5) |
C12N 9/80
|
Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides |
C12N 9/82
|
Asparaginase |
C12N 9/84
|
Penicillin amidase |
C12N 9/86
|
Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase |
C12N 9/88
|
Lyases (4.) |
C12N 9/90
|
Isomerases (5.) |
C12N 9/92
|
Glucose isomerase |
C12N 9/94
|
Pancreatin |
C12N 9/96
|
Stabilising an enzyme by forming an adduct or a compositionForming enzyme conjugates |
C12N 9/98
|
Preparation of granular or free-flowing enzyme compositions |
C12N 9/99
|
Enzyme inactivation by chemical treatment |
C12N 11/00
|
Carrier-bound or immobilised enzymesCarrier-bound or immobilised microbial cellsPreparation thereof |
C12N 11/02
|
Enzymes or microbial cells immobilised on or in an organic carrier |
C12N 11/04
|
Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres |
C12N 11/06
|
Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent |
C12N 11/08
|
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer |
C12N 11/10
|
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate |
C12N 11/12
|
Cellulose or derivatives thereof |
C12N 11/14
|
Enzymes or microbial cells immobilised on or in an inorganic carrier |
C12N 11/16
|
Enzymes or microbial cells immobilised on or in a biological cell |
C12N 11/18
|
Multi-enzyme systems |
C12N 11/082
|
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds |
C12N 11/084
|
Polymers containing vinyl alcohol units |
C12N 11/087
|
Acrylic polymers |
C12N 11/089
|
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds |
C12N 11/091
|
Phenol resinsAmino resins |
C12N 11/093
|
Polyurethanes |
C12N 11/096
|
PolyestersPolyamides |
C12N 11/098
|
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer formed in the presence of the enzymes or microbial cells |
C12N 13/00
|
Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves |
C12N 15/00
|
Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor |
C12N 15/01
|
Preparation of mutants without inserting foreign genetic material thereinScreening processes therefor |
C12N 15/02
|
Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion |
C12N 15/03
|
Bacteria |
C12N 15/04
|
Fungi |
C12N 15/05
|
Plant cells |
C12N 15/06
|
Animal cells |
C12N 15/07
|
Human cells |
C12N 15/08
|
Cells resulting from interspecies fusion |
C12N 15/09
|
Recombinant DNA-technology |
C12N 15/10
|
Processes for the isolation, preparation or purification of DNA or RNA |
C12N 15/11
|
DNA or RNA fragmentsModified forms thereof |
C12N 15/12
|
Genes encoding animal proteins |
C12N 15/13
|
Immunoglobulins |
C12N 15/14
|
Human serum albumins |
C12N 15/15
|
Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin |
C12N 15/16
|
Hormones |
C12N 15/17
|
Insulins |
C12N 15/18
|
Growth hormones |
C12N 15/19
|
InterferonsLymphokinesCytokines |
C12N 15/20
|
Interferons |
C12N 15/21
|
Alpha-interferons |
C12N 15/22
|
Beta-interferons |
C12N 15/23
|
Gamma-interferons |
C12N 15/24
|
Interleukins |
C12N 15/25
|
Interleukin-1 |
C12N 15/26
|
Interleukin-2 |
C12N 15/27
|
Colony stimulating factors |
C12N 15/28
|
Tumor necrosis factors |
C12N 15/29
|
Genes encoding plant proteins, e.g. thaumatin |
C12N 15/30
|
Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria |
C12N 15/31
|
Genes encoding microbial proteins, e.g. enterotoxins |
C12N 15/32
|
Bacillus crystal proteins |
C12N 15/33
|
Genes encoding viral proteins |
C12N 15/34
|
Proteins from DNA viruses |
C12N 15/35
|
Parvoviridae, e.g. feline panleukopenia virus, human parvovirus |
C12N 15/36
|
Hepadnaviridae |
C12N 15/37
|
Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 |
C12N 15/38
|
Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus |
C12N 15/39
|
Poxviridae, e.g. vaccinia virus, variola virus |
C12N 15/40
|
Proteins from RNA viruses, e.g. flaviviruses |
C12N 15/41
|
Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses |
C12N 15/42
|
Foot-and-mouth disease virus |
C12N 15/43
|
Poliovirus |
C12N 15/44
|
Orthomyxoviridae, e.g. influenza virus |
C12N 15/45
|
Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses |
C12N 15/46
|
Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus |
C12N 15/47
|
Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus |
C12N 15/48
|
Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus |
C12N 15/49
|
Lentiviridae, e.g. immunodeficiency viruses such as HIV, visna-maedi virus, equine infectious anaemia virus |
C12N 15/50
|
Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus |
C12N 15/51
|
Hepatitis viruses |
C12N 15/52
|
Genes encoding for enzymes or proenzymes |
C12N 15/53
|
Oxidoreductases (1) |
C12N 15/54
|
Transferases (2) |
C12N 15/55
|
Hydrolases (3) |
C12N 15/56
|
Hydrolases (3) acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme |
C12N 15/57
|
Hydrolases (3) acting on peptide bonds (3.4) |
C12N 15/58
|
Plasminogen activators, e.g. urokinase, TPA |
C12N 15/59
|
Chymosin |
C12N 15/60
|
Lyases (4) |
C12N 15/61
|
Isomerases (5) |
C12N 15/62
|
DNA sequences coding for fusion proteins |
C12N 15/63
|
Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression |
C12N 15/64
|
General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host |
C12N 15/65
|
Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression using markers |
C12N 15/66
|
General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligationUse of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease |
C12N 15/67
|
General methods for enhancing the expression |
C12N 15/68
|
Stabilisation of the vector |
C12N 15/69
|
Increasing the copy number of the vector |
C12N 15/70
|
Vectors or expression systems specially adapted for E. coli |
C12N 15/71
|
Expression systems using regulatory sequences derived from the trp-operon |
C12N 15/72
|
Expression systems using regulatory sequences derived from the lac-operon |
C12N 15/73
|
Expression systems using phage lambda regulatory sequences |
C12N 15/74
|
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora |
C12N 15/75
|
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus |
C12N 15/76
|
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for ActinomycesVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces |
C12N 15/77
|
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for CorynebacteriumVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Brevibacterium |
C12N 15/78
|
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas |
C12N 15/79
|
Vectors or expression systems specially adapted for eukaryotic hosts |
C12N 15/80
|
Vectors or expression systems specially adapted for eukaryotic hosts for fungi |
C12N 15/81
|
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts |
C12N 15/82
|
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells |
C12N 15/83
|
Viral vectors, e.g. cauliflower mosaic virus |
C12N 15/84
|
Ti-plasmids |
C12N 15/85
|
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells |
C12N 15/86
|
Viral vectors |
C12N 15/87
|
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation |
C12N 15/88
|
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle |
C12N 15/89
|
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection |
C12N 15/90
|
Stable introduction of foreign DNA into chromosome |
C12N 15/113
|
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides |
C12N 15/115
|
Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith |
C12N 15/117
|
Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs |
C12N 15/861
|
Adenoviral vectors |
C12N 15/863
|
Poxviral vectors, e.g. vaccinia virus |
C12N 15/864
|
Parvoviral vectors |
C12N 15/866
|
Baculoviral vectors |
C12N 15/867
|
Retroviral vectors |
C12N 15/869
|
Herpesviral vectors |
C12N 15/873
|
Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos |
C12N 15/877
|
Techniques for producing new mammalian cloned embryos |